Artificial Intelligence > Rewiring the Future

Rewiring the Future

Mayo Clinic's BIONIC Initiative Aims to Heal the Brain

By Alison Caldwell, Ph.D. Illustrations by Jacey Tec

Every thought, memory and movement generates an electrical signal in the brain. For decades, clinicians have recorded these signals during routine diagnostics and surgical care without fully understanding their meaning. But these thousands upon thousands of datapoints could reveal how the brain works, how it changes with age and how it breaks down in disease. Mayo Clinic's BIONIC initiative aims to crack the code.

Despite the wealth of recording data, the field of neuroscience remains in its infancy. The brain's circuitry is far more complex than many realize, and the gap between what we know and what we need to understand has created an urgent challenge: How do we translate the brain's own language into treatments that can halt or reverse neurological disease?

Mayo Clinic's institution-wide initiative brings together neurologists, neurosurgeons, bioengineers, data scientists and neurophysiologists in a rich ecosystem that aims to answer that question through three interconnected approaches.

The program plans to do this first by collecting and harmonizing electrical signaling data into a comprehensive biobank called NeuroElectromics. This will create the next frontier in neuroscientific discovery and provide an unparalleled resource for the greater neuroscience community.

Secondly, researchers will apply advanced artificial intelligence (AI) and machine learning modeling to identify early biomarkers for neurological disease — patterns in electrical signals that could predict a person's risk for dementia, epilepsy, mood disorders and degenerative conditions long before symptoms are visible.

Finally, Mayo Clinic experts will close the loop, by turning those insights into precision neuromodulation therapies that speak back to the brain, allowing it to heal itself.

The vision is ambitious, moving from reactive symptom management to proactive, personalized care guided by the brain's own signals. Instead of waiting for decline or relying solely on surgical intervention, these tools would monitor activity and respond in real time, creating a therapeutic conversation between the brain and the device. Implantable devices could sense abnormal activity and deliver electrical stimulation to stop a seizure before it starts. Wearable devices could rewire abnormal neural circuits through noninvasive stimulation. Cell-enhanced implants could release neurotransmitters or critical proteins precisely where needed. Simple recordings of voice, eye movement and gait can serve as early biomarkers of deterioration.

Turning this vision into reality requires more than technology alone. It demands leaders who move seamlessly between clinic and lab — clinicians who can listen closely to the brain's activity and translate it into care for people living with serious or complex diseases.

At Mayo Clinic, that work comes to life through several of the physicians driving BIONIC forward, each bringing a distinctive perspective and expertise to this transformative effort.